Serial studies were designed to characterized changes in osmoregulation throughout gestation. Eight women underwent a 2-h infusion of hypertonic saline before conception, during gestational weeks 5-8, 10-12, and 28-33, and then 10-12 wk postpartum. Basal plasma osmolality (Posmol) was already significantly decreased by 5-8 wk (P less than 0.001) and remained 10 mosmol.kg-1 below nonpregnant values throughout pregnancy. The apparent threshold for AVP release (defined as the abscissal intercept of the regression line relating plasma AVP [PAVP] to Posmol) was also decreased significantly throughout gestation, as was the osmotic threshold for thirst (derived from analogue scales relating desire to drink to Posmol). The decrement in osmotic thirst threshold appeared to precede that for AVP release, and consistent with this 24-h urine volumes were significantly greater at 5-8 wk gestation (P less than 0.05). The slopes of each regression equation defining PAVP vs. Posmol (whose r values ranged from 0.79 to 0.99), very reproducible before and after pregnancy, were similar at 5-8 and 10-12 wk, but were markedly reduced in the third trimester (P less than 0.001). These volunteers had randomly undergone an additional infusion before conception (both tests in the luteal phase of the menstrual cycle) when 10,000 IU of human chorionic gonadotrophin (hCG) had been given intramuscularly over a 5-d period. Serum hCG values between 0.2 and 3.3 U.ml-1 […] 
Introduction
Serial studies were designed to characterize changes in osmoregulation throughout gestation. Eight women underwent a 2-h infusion of hypertonic saline before conception, during gestational weeks 5-8, 10-12, and 28-33, and then 10-12 wk postpartum. Basal plasma osmolality (P.,6.l,1) was already significantly decreased by 5-8 wk (P < 0.001) and remained 10 mosmol' kg-' below nonpregnant values throughout pregnancy. The apparent threshold for AVP release (defined as the abscissal intercept of the regression line relating plasma AVP IPAvPI to P..,) was also decreased significantly throughout gestation, as was the osmotic threshold for thirst (derived from analogue scales relating desire to drink to P~..,,1). The decrement in osmotic thirst threshold appeared to precede that for AVP release, and consistent with this 24-h urine volumes were significantly greater at 5-8 wk gestation (P < 0.05). The slopes of each regression equation defining PAVP vs. P.., (whose r values ranged from 0.79 to 0.99), very reproducible before and after pregnancy, were similar at 5-8 and 10-12 wk, but were markedly reduced in the third trimester (P < 0.001). These volunteers had randomly undergone an additional infusion before conception (both tests in the luteal phase of the menstrual cycle) when 10,000 IU of human chorionic gonadotrophin (hCG) had been given intramuscularly over a 5-d period.
Serum hCG values between 0.2 and 3.3 U. ml-' were lower than usually seen in pregnancy, but the osmotic thresholds for AVP release and thirst decreased by 3 and 4 mosmol* kg-l, respectively (P < 0.05). Finally we studied a patient with a molar pregnancy in whom thresholds for hormone release and thirst were both decreased to values resembling normal gestation and remained so for -6 wk postevacuation, only normalizing when hCG had virtually disappeared from her serum. In contrast, thresholds increased within the first two puerperal weeks in two women with normal pregnancies. These data demonstrate (a) osmotic thresholds for both AVP release and thirst decrease within the very first gestational weeks; (b) increment in PAvP per unit increase in P.,.,, is reduced late in gestation; and (c) hCG may be involved in the osmoregulatory changes of pregnancy.
Reprint requests from Great Britain and the Eastern Hemisphere should be addressed to Dr. Davison Receivedfor publication 25 June 1987 and in revisedform 30 September 1987. Body tonicity decreases during human pregnancy, which results in a decrement in plasma osmolality (P,=01)' to -10 mosmol* kg-' below nonpregnant levels. These changes occur during the early weeks of gestation, reach their lowest levels by gestational week 10, and remain fairly constant thereafter until term (1) . On the basis of observations in rodents and a single study in third trimester women we suggested that this new steady state Pomol was due to parallel decrements in the osmotic thresholds for AVP release and thirst, and indeed, in late human gestation there are decrements in these two thresholds of 6 and 10 mosmol * kg-', respectively, compared with values recorded postpartum (2-4). The current study was designed to characterize osmotic AVP secretory and thirst thresholds in early human pregnancy to confirm our postulate and to explore if changes observed correlate with any of the known humoral and hemodynamic alterations in normal gestation.
Women wishing to conceive were serially tested. Before conception they were studied twice, once in the basal state and again after having been pretreated with human chorionic gonadotrophin (hCG). They were then retested during gestational weeks 5-8, 10-12, and 28-33, and again postpartum. Also studied was a single patient with a hydatiform mole.
The results demonstrate that the thresholds for AVP release and thirst decline early in the first trimester and explain the rapid decline in body tonicity during the initial months of gestation. Observations made when testing the patient with a molar pregnancy demonstrate that the osmoregulatory alterations of gestation do not require the presence of the fetus. Furthermore, the results produced by hCG administration, combined with those observed in the woman whose hydatiform mole was evacuated, suggest that hCG may be involved in the decrements in the osmotic thresholds that occur in pregnancy. Finally, these serial studies revealed that the "apparent" sensitivity of the AVP secretory response to osmotic stimuli (that is the increase in plasma AVP (PAvp) per unit increment in Posmoi) was decreased in late pregnancy, data which might relate to some of the recently described polyuric syndromes of late gestation.
Methods

Subjects
Serial studies were performed on eight normotensive healthy subjects: twice before conception, once between their 5-8, 10-12, and 28-33 gestational weeks, respectively, and again 8-10 wk postpartum when none were breast-feeding or ingesting oral contraceptives. In addition, one patient with a molar gestation was studied before and four times after surgical evacuation of the hydatiform mole. Two other women studied during the third trimester underwent serial infusion tests in the puerperium. All subjects gave informed consent in writing to protocols approved by both the Ethical Committee of the Newcastle Health Authority and the Clinical Investigation Committee of the University of Chicago, Pritzker School of Medicine. With the exception of the woman with the molar pregnancy, all volunteers had successful pregnancies.
Protocols
Each test was started at 9 a.m. with the volunteer sitting comfortably in a chair. 30 min later control blood samples were taken before an infusion of 5% saline was started at a rate of 0.06 ml * kg-Imin-' and continued for 2 h using a constant-infusion pump. Repeat blood samples were taken at 1 5-min intervals and blood pressure was measured at 5-min intervals during the study with an automatic recording device.
During the study thirst was evaluated using an uncalibrated visual linear analogue scale using modifications of methods originally described by Rolls (5-7). Subjects rated their own thirst sensations on an unmarked 10-cm line, 0 representing "not thirsty" and 10 "extremely thirsty". Before the infusion they characterized their own thirst rating and were not automatically given a zero rating. By relating the value for the distance from the zero end ofthe line to concurrent osmolality, a stimulus-response curve for the thirst mechanism was constructed, its form similar to that relating PAVP to Poem,.. In addition, subjects were independently asked to state when they experienced a strong conscious desire to drink.
hCG. Women wishing to conceive who had volunteered for the serial pregnancy study underwent two infusion tests, each performed during a luteal phase oftheir menstrual cycle (confirmed by measuring plasma progesterone levels). 5 and 3 d before one of the preconception studies (order selected randomly), the volunteer received two intramuscular injections of 5,000 IU of hCG (gonadotrophon L.H., 5,000 IU with solvent; Paines and Byrne Ltd., Greenford, England). The doses were those already in use for certain infertility treatment regimens, and preliminary data (n = 5) demonstrated that serum hCG values were highest on day 5 (2 d after second [booster] injection), but declined thereafter.
Patient with a molar gestation. An 18-yr-old caucasian nullipara who presented with a threatened abortion during her 11th gestational week and was diagnosed by ultrasound as having a molar pregnancy agreed to undergo infusion studies just before evacuation of the mole (when serum hCG levels were 4,000 U * ml-') and 5, 13, 4 1, and 91 d postevacuation. In addition, two gravidas tested only once in late pregnancy were retested at 4 d, 2 wk, 6 wk, and 13 wk during the puerperium.
Assay methods
Blood for osmolality and electrolyte determinations was collected in chilled heparinized tubes, small portions immediately drawn for microhematocrit determination, and the remainder centrifuged at 40C.
Osmolality was determined on freshly separated plasma and the remaining sample was stored at -20'C until used (2) . Blood for AVP determination was collected in a 10-ml syringe containing 0.1 ml phenanthroline (1-10-phenanthroline monohydrate, Sigma Chemical Co., St. Louis, MO) solution (60 mg ml-') and then rapidly added to chilled heparinized tubes, centrifuged in the cold, and extracted within 3 h of venepuncture. Validation of this technique, which immediately inactivates the high concentrations of cystine aminopeptidase (vasopressinase) present in the plasma of gravidas, is detailed elsewhere (2) .
Radioimmunoassay of A VP. Details of our extraction technique and assay procedures have been published (2) . Briefly, plasma is extracted by a modification of the acetone method and 200-MUl samples are assayed by a nonequilibrium method. The tracer has a high specific activity (> 1,000 Ci Mg-'); highly purified AVP (potency 400 U * mg-'; lot 800207, Ferring Arzneimittal GmbH, Wittland, FRG) is utilized for iodination and standards, and our antiserum (10169) is specific and sensitive, as assay sensitivity is 0.1 pg per assay tube while its 50% displacement is 1.6 pg per assay tube.
Radioimmunoassay ofhCG. Serum hCG was measured by radioimmunoassay using a kit produced by Amersham International (Amersham, United Kingdom). The assay utilizes an antiserum against the beta subunit of hCG, but the whole molecule is used for iodination as well as the standard curve (8) . The serum concentrations are expressed as units of hCG per milliliter (U -ml-') of the World Health Organization International Reference Preparation for Immunoassay (73:537). Crossreactivity with luteinizing hormone is only 2.5% on a molar basis. Determinations on serum samples obtained from women in the follicular phase oftheir cycles (n = 30) and men (n = 10) gave values that are consistently below the assays level of detection (0.005 U* ml-'). Two values > 0.01 U* ml-' after a missed period are diagnostic of early pregnancy.
Other analytical procedures included determination of osmolality by freezing point depression and sodium by flame photometry.
Statistical analyses
The primary objective of these analyses was to assess whether the relationships between P.,,01 and PAVP or between P,,,01 and thirst changed with the administration of hCG or during the course of pregnancy. The data points (n = 9) obtained during the infusion of each patient (n = 8) at each test occasion (n = 6) were used in separate least-squares linear regressions to obtain individual slopes and to calculate the abscissal intercepts or threshold values. Analyses of variance were then performed using the generalized linear interactive model on the values so obtained to investigate the significance of the change in the relationships at the different test occasions (9) . Where a significant change (P < 0.05) between test occasions was detected a value for the least significant difference between means at the 5% probability level was calculated from the residual mean square using the method of Snedecor and Cochran (10).
Other paired comparisons were performed using Student's t test. For all analyses, values of P < 0.05 were considered significant. All data are given as mean±SD.
Results
Serial infusions throughout gestation
Studies were performed on eight volunteers, whose ages ranged from 22 to 31 yr; five of whom were nulliparas and the remainder multigravidas (one to three previous gestations). The slow infusion of 5% saline resulted in a gradual rise in body tonicity (always < 2% * h-') during each phase of the serial study (Table I) . Mean arterial pressure was stable through the first 90 min but then increased by 8.7±2.4 mmHg. Hematocrit decreased by 2-5%, again mainly towards the end ofthe infusion. The increments in Posmol from before to the end of the 2-h infusions were always accompanied by concomittant increases in PAVP (P < 0.001).
All the data points for changes in PAVP with elevation of P.., from each patient on each test occasion are shown in Fig.   3 . The results of the linear regression analyses performed on the data from each individual hypertonic saline infusion are presented in Table II f interest, the slope for the regression equations which defines the "apparent" sensitivity of the osmotic response (PAvp VS. Posmol) was decreased by > 50% during the third trimester,3 although the osmotic threshold for hormonal release was similar to that measured earlier in pregnancy (Table III) . The slopes measured before and after pregnancy (0.61 and 0.59, respectively), like the osmotic thresholds for hormone release (285 and 286 mosmol kg-', respectively), were also similar before and after pregnancy, confirming that these values remain stable over time in nonpregnant populations and underscore the reproducibility of the infusion technique in our hands. In Table I are 24-h urine volumes, which were slightly but significantly (P < 0.05) increased at 5-8 wk, although daily solute excretion was similar at each study phase. In addition, the volumes of water ingested (to satiety) after the 2-h hypertonic infusion were significantly greater (P < 0.01) both at 5-8 and 10-12 wk gestation (Table III) .
Studies in the patient with a molar pregnancy Table IV summarizes data obtained before and up to 95 d after evacuation of a hydatiform mole in patient A.W. Basal Posmoi was markedly reduced below norms for nongravid women when first studied (1 wk gestation) at a time when serum hCG was 4,000 U. ml-'. Body tonicity remained decreased through her 41st postevacuation day, at a time when circulating hCG was still elevated. Hypertonic saline infusion tests before suction curettage and at 5, 13, and 41 d afterwards revealed decreased osmotic thresholds for AVP release and thirst, resembling those during normal gestation. When tested on day 95, circulating hCG had virtually disappeared (0.01 Uml-'), while basal Posmol and the osmotic threshold had returned to nonpregnant levels (Table IV and Fig. 4) . Fig. 4 and Table V also contain data from two women who had normal term deliveries (ages 26 and 27 yr, one nullipara (K.T.) and one multipara [B.B.]). Each was tested in the third trimester and four times in the puerperium. Basal P.mo, had increased by postpartum day 4 (as had the osmotic thresholds for hormone release and thirst) and was normal by puerperal week 2.
3. An analysis of variance of these slopes demonstrated a significant effect of test occasion (F5,35 = 8.93, P < 0.001; least significant difference between mean slopes was 0.16 at P < 0.05). The performance of serial studies demonstrated significant changes in the "apparent" sensitivity to osmotic stimuli between early and late pregnancy, as the slope of the regression line characterizing PAVP vs. Posmol was lower in the third trimester, while that measured during the first trimester were similar to nonpregnant values. These results at first appear at variance with our previous study ofwomen studied in the third trimester and 10-12 wk postpartum, in which the slopes during each period were similar. At that time, however, we noted that "although the postpartum slope was not significantly different from the slope noted during pregnancy, it was slightly steeper," suggesting the need for further studies (2) . Since then, we have altered our protocols, increasing the number of blood samples over the 2-h infusion from six to eight and utilized an analogue scale to determine the thirst threshold. In addition, aware that an excessively rapid increment in Posmol may result in exaggerated AVP secretion, we carefully controlled the infusion rate in each study to ensure that rise in tonicity was always < 2% * h-1. Such steps have refined our capabilities and increased the precision ofthe infusion tests as evidenced by the r values ofthe individual regression lines and the reproducibility of the studies performed before and after pregnancy (Table  II) . With these improvements the decrease in the osmotic sensitivity during late pregnancy becomes more obvious.
Reasons for the decrease in the apparent osmotic sensitivity are not obvious from our data. There could be a true decrease in the AVP response to a rise in tonicity, as may occur in nongravid patients with primary aldosteronism and other hypervolemic states (15) . Intravascular volume is increased 30-40% in third trimester women and this might cause suppression of the osmotic response. Such an explanation, however, would contrast with observations in rodents, which consistently indicate that the increments in absolute volume occurring during gestation are "sensed" as effectively normal or slightly decreased (16, 17) .
Another possible explanation for the shallower slope is that the osmotically stimulated hormonal response is not decreased but actually normal or even increased, but the metabolic clearance rate (MCR) of AVP is markedly enhanced. In favor of this latter suggestion is our recent observation that the MCR is increased three-to fourfold in late gestation, but not at all or only minimally so in the first trimester (18) . Furthermore, these increments seem to parallel the marked increases in levels of circulating cystine-aminopeptidase (vasopressinase), which are manyfold those noted at 10-12 wk * During 2-h hypertonic saline infusion for eight subjects studied serially before, during, and after pregnancy. Results of regression analyses are expressed in the form PAVP or thirst = slope (P.,O -abscissal intercept). Also given are mean values for P.., at which conscious desire to drink occurred and mean (±SD) values for water ingested at end of infusion. t Individual data are given in Table II . § Water drank to satiety. Relative to preconception value, "P P < 0.05; 1 P < 0.01; ** P < 0.001. Posdo when values during either early or late gestation are compared with those of age-matched virgins (3, 19) . This species produces no detectable vasopressinase.
Mechanisms responsible for the decreases in osmotic thresholds during pregnancy are unknown. Furthermore, this phenomenon is species dependent, body tonicity decreasing markedly in both rodent and human pregnancy but remaining unaltered in gravid sheep (3, 4, 19, 20) . In the rat we have systematically tested the roles of several hormones whose levels increase during gestation, and investigated the effect of hemodynamic and volume changes that occur in rodent pregnancy and have failed to implicate estrogens, progesterone, prolactin, components of the renin-angiotensin, or opioids in the observed decrements in PosOl (19) . Similarly, decreases in "effective" volume or blood pressure are not effectors of these changes (16, 21) . Thus, in the present studies it was of interest to observe that pretreatment with hCG did result in significant, albeit small, decreases in body tonicity and the osmotic thresholds for thirst and AVP release. The reason for these minimal changes may be that serum hCG levels produced in our protocol were extremely low, compared with values measured throughout pregnancy (8, 22, 23) (26) (27) (28) (29) .
Downward resetting of the osmostat, in the absence of hypovolemia or hypotension, has been reported in patients with carcinoma of the lung (6) . As in pregnancy, the basic cause of the resetting is unknown, but may be related to hormones these tumors secrete that include hCG (30) .
Thirst threshold has traditionally been designated at the P.01 at which a subject experiences a strong conscious desire to drink (i.e., onset of severe thirst) (28). In our earlier study using such methodology the values for third trimester and postpartum women were 287 and 298 mosmol* kg-', respectively (2). That is 10-1 1 mosmol * kg-' above the AVP secretory threshold. Recently it has been suggested that absolute thirst onset should be replaced by a value derived from serial assessment of thirst during hypertonic saline infusion (7). This is because thirst perception usually occurs gradually, probably in a progressive fashion over a wide range of plasma osmolalities, giving the investigator the opportunity to construct analogue scales that pinpoint the apparent threshold more accurately. A value derived in this manner by Thomson et al. (7) in nongravid subjects of 281 mosmol* kg-' was is in fact 4 mosmol* kg-' less than the osmotic threshold for AVP release (285 mosmol-kg-') they obtained. Such results might infer that mild polyuria should be commonplace, which it is not. In the present study, the calculated method threshold was higher than that for hormone release both during and after gestation (range, 2 to 5 mosmol* kg-'), thus fitting in more accurately with what is known about the physiology of the mechanism of thirst and urine concentration and dilution. Incidentally, thresholds were 11-13 mosmol . kg-' greater, by the "traditional" method (Table III, 
